3B Blackbio

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE994E01018
  • NSEID:
  • BSEID: 532067
INR
1,260.00
-18.25 (-1.43%)
BSENSE

Dec 05

BSE+NSE Vol: 3.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
56.14
48.58
33.46
29.00
47.89
165.17
15.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
56.14
48.58
33.46
29.00
47.89
165.17
15.26
Raw Material Cost
14.81
12.63
10.36
9.25
18.56
29.50
7.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
-0.32
0.32
-0.27
-0.40
0.67
-0.10
Employee Cost
6.39
3.71
3.31
2.12
1.65
2.95
1.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
8.37
5.44
5.24
3.54
3.86
15.71
1.96
Total Expenditure (Excl Depreciation)
29.57
21.46
19.23
14.63
23.67
48.83
10.66
Operating Profit (PBDIT) excl Other Income
26.57
27.12
14.23
14.37
24.22
116.34
4.60
Other Income
9.82
7.13
5.71
3.19
3.49
0.13
0.57
Operating Profit (PBDIT)
36.39
34.25
19.94
17.56
27.71
116.47
5.17
Interest
0.05
0.04
0.05
0.10
0.10
0.15
0.13
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
36.34
34.21
19.89
17.46
27.61
116.32
5.04
Depreciation
0.86
0.54
0.43
0.41
0.33
0.27
0.30
Profit Before Tax
35.48
33.66
19.45
17.05
27.28
116.04
4.74
Tax
7.80
7.50
4.66
4.02
6.46
29.11
1.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
27.68
26.16
14.79
13.03
20.81
86.93
3.67
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
27.68
26.16
14.79
13.03
20.81
86.93
3.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.38
-0.39
0.35
-0.02
-2.52
-12.76
-0.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.30
25.77
15.14
13.01
18.30
74.17
3.27
Equity Capital
8.57
8.57
8.57
8.57
7.51
7.51
6.41
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
262.44
216.91
162.68
144.47
124.56
16.36
11.34
Earnings per share (EPS)
31.86
30.07
17.67
15.18
24.37
98.76
5.1
Diluted Earnings per share
32.31
30.54
17.27
15.21
24.37
115.78
4.89
Operating Profit Margin (Excl OI)
47.33%
55.83%
42.53%
49.55%
50.57%
70.44%
30.14%
Gross Profit Margin
64.73%
70.42%
59.44%
60.21%
57.65%
70.42%
33.03%
PAT Margin
49.31%
53.85%
44.2%
44.93%
43.45%
52.63%
24.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 15.56% vs 45.19% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 5.94% vs 70.21% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is -2.03% vs 90.58% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 25.00% vs -20.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of 3B Blackbio With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
56.14
193.69
-137.55
-71.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
56.14
193.69
-137.55
-71.02%
Raw Material Cost
14.81
33.16
-18.35
-55.34%
Purchase of Finished goods
0.00
21.04
-21.04
-100.00%
(Increase) / Decrease In Stocks
0.00
8.35
-8.35
-100.00%
Employee Cost
6.39
35.67
-29.28
-82.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8.37
43.33
-34.96
-80.68%
Total Expenditure (Excl Depreciation)
29.57
141.54
-111.97
-79.11%
Operating Profit (PBDIT) excl Other Income
26.57
52.15
-25.58
-49.05%
Other Income
9.82
9.14
0.68
7.44%
Operating Profit (PBDIT)
36.39
61.29
-24.90
-40.63%
Interest
0.05
10.25
-10.20
-99.51%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
36.34
51.04
-14.70
-28.80%
Depreciation
0.86
42.42
-41.56
-97.97%
Profit Before Tax
35.48
8.62
26.86
311.60%
Tax
7.80
3.52
4.28
121.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
27.68
5.11
22.57
441.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
27.68
5.11
22.57
441.68%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.38
0.00
-0.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.30
5.11
22.19
434.25%
Equity Capital
8.57
10.64
-2.07
-19.45%
Face Value
10.00
2.00
0.00
Reserves
262.44
0.00
262.44
Earnings per share (EPS)
31.86
0.96
30.90
3,218.75%
Diluted Earnings per share
32.31
0.96
31.35
3,265.62%
Operating Profit Margin (Excl OI)
47.33%
26.92%
0.00
20.41%
Gross Profit Margin
64.73%
26.35%
0.00
38.38%
PAT Margin
49.31%
2.64%
0.00
46.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 56.14 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 15.56% vs 45.19% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 27.30 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 5.94% vs 70.21% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.57 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -2.03% vs 90.58% in Sep 2024

Half Yearly - Interest
Interest 0.05 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 25.00% vs -20.00% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.33%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024